Zucker School of Medicine at Hofstra/Northwell (North Shore University Hospital/LIJ)
Hematology and Oncology fellowship · Manhasset, NY · Program website
This program's roster hasn't been collected yet, so there's no list of its own faculty and papers. Below is Donald & Barbara Zucker School of Medicine at Hofstra/Northwell's research in hematology and oncology, which the program shares with other departments and affiliated hospitals.
About Donald & Barbara Zucker School of Medicine at Hofstra/Northwellinstitution-wide hematology and oncology research
Hematology and Oncology publications from Donald & Barbara Zucker School of Medicine at Hofstra/Northwell + Northwell Health and affiliated institutions, since 2022. Updated 2026-11-06; refreshed daily.
193
works per year
27th of 74 hematology and oncology fellowship programs
+20.3%
2-year growth
20th of 74 hematology and oncology fellowship programs
15.1%
in top 10% of field (works before 2025)
60th of 72 hematology and oncology fellowship programs
31.5%
cited above world average
61st of 72 hematology and oncology fellowship programs
Works per year · * 2026 so far
Oncology · 697Hematology · 270
Hematology and Oncology research topics at Donald & Barbara Zucker School of Medicine at Hofstra/Northwell
Papers in the window; each links to the list on OpenAlex.
- Pancreatic and Hepatic Oncology Research 171
- Cancer Immunotherapy and Biomarkers 95
- Acute Myeloid Leukemia Research 58
- Cancer survivorship and care 49
- Cutaneous Melanoma Detection and Management 44
- Multiple Myeloma Research and Treatments 44
- Colorectal Cancer Surgical Treatments 39
- Autoimmune and Inflammatory Disorders Research 39
Most cited at Donald & Barbara Zucker School of Medicine at Hofstra/Northwell since 2024
All hematology and oncology papers there on OpenAlex
- Advancements and challenges in CAR T cell therapy in autoimmune diseasesGeorg Andreas Schett et al. · Nature Reviews Rheumatology · 2024 · PubMed · cited 274
- Management of Locally Advanced Rectal Cancer: ASCO GuidelineAaron James Scott et al. · Journal of Clinical Oncology · 2024 · PubMed · cited 204
- CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitorsFerdinandos Skoulidis et al. · Nature · 2024 · PubMed · cited 201
- Kinase-impaired BTK mutations are susceptible to clinical-stage BTK and IKZF1/3 degrader NX-2127Skye Montoya et al. · Science · 2024 · PubMed · cited 181
- Global, regional, and national burden of breast cancer among females, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023Kayleigh Pavitra Bhangdia et al. · The Lancet Oncology · 2026 · PubMed · cited 174
- REDISCOVER International Guidelines on the Perioperative Care of Surgical Patients With Borderline-resectable and Locally Advanced Pancreatic CancerUgo Boggi et al. · Annals of Surgery · 2024 · PubMed · cited 75
- Diagnosis and management of immune checkpoint inhibitor–associated nephrotoxicity: a position statement from the American Society of Onco-nephrologySandra M. Herrmann et al. · Kidney International · 2024 · PubMed · cited 70
- Society for Immunotherapy of Cancer (SITC) consensus statement on essential biomarkers for immunotherapy clinical protocolsTricia R. Cottrell et al. · Journal for ImmunoTherapy of Cancer · 2025 · PubMed · cited 61
- American Society for Gastrointestinal Endoscopy guideline on the role of endoscopy in the diagnosis and management of solid pancreatic masses: summary and recommendationsJorge D. Machicado et al. · Gastrointestinal Endoscopy · 2024 · PubMed · cited 60
- Global, regional and national burden of dietary iron deficiency from 1990 to 2021: a Global Burden of Disease studySooji Lee et al. · Nature Medicine · 2025 · PubMed · cited 57